Literature DB >> 28771676

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.

Abraham S Kanate1, Alyssa DiGilio2, Kwang W Ahn2,3, Monzr Al Malki4, Eric Jacobsen5, Amir Steinberg6, Nelson Hamerschlak7, Mohamed Kharfan-Dabaja8, Rachel Salit9, Edward Ball10, Qaiser Bashir11, Amanda Cashen12, Daniel Couriel13, Jose Diez-Martin14, Emmanuel Katsanis15, Yulia Linhares16, Shahram Mori17, Richard Nash18, Attaphol Pawarode19, Miguel-Angel Perales20, Colin D Phipps21, Carol Richman22, Bipin N Savani23, Michael Y Shapira24, Patrick Stiff25, Roger Strair26,27, Timothy S Fenske26,27, Sonali M Smith28, Anna Sureda29, Horatiu Olteanu30, Mehdi Hamadani2.   

Abstract

Entities:  

Keywords:  allogeneic haematopoietic cell transplantation; extranodal NK/T-cell lymphoma; non-relapse mortality; relapse; survival

Mesh：

Year:  2017        PMID： 28771676      PMCID： PMC5796874          DOI： 10.1111/bjh.14879

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

Review 1.  How I treat NK/T-cell lymphomas.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Blood       Date:  2013-05-07       Impact factor: 22.113

2.  Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell Lymphoma.

Authors:  Parameswaran Hari; Renju V Raj; Horatiu Olteanu
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

3.  Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.

Authors:  J Iqbal; D D Weisenburger; A Chowdhury; M Y Tsai; G Srivastava; T C Greiner; C Kucuk; K Deffenbacher; J Vose; L Smith; W Y Au; S Nakamura; M Seto; J Delabie; F Berger; F Loong; Y-H Ko; I Sng; X Liu; T P Loughran; J Armitage; W C Chan
Journal:  Leukemia       Date:  2010-11-05       Impact factor: 11.528

4.  Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.

Authors:  Naoko Murashige; Masahiro Kami; Yukiko Kishi; Sung-Won Kim; Masami Takeuchi; Kosei Matsue; Yoshinobu Kanda; Makoto Hirokawa; Yoshinari Kawabata; Tomoko Matsumura; Eiji Kusumi; Noriyuki Hirabayashi; Koji Nagafuji; Ritsuro Suzuki; Kengo Takeuchi; Kazuo Oshimi
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

5.  Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.

Authors:  Ghee Chong Koo; Soo Yong Tan; Tiffany Tang; Song Ling Poon; George E Allen; Leonard Tan; Soo Ching Chong; Whee Sze Ong; Kevin Tay; Miriam Tao; Richard Quek; Susan Loong; Kheng-Wei Yeoh; Swee Peng Yap; Kuo Ann Lee; Lay Cheng Lim; Daryl Tan; Christopher Goh; Ioana Cutcutache; Willie Yu; Cedric Chuan Young Ng; Vikneswari Rajasegaran; Hong Lee Heng; Anna Gan; Choon Kiat Ong; Steve Rozen; Patrick Tan; Bin Tean Teh; Soon Thye Lim
Journal:  Cancer Discov       Date:  2012-06-15       Impact factor: 39.397

6.  Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.

Authors:  Seok Jin Kim; Joon Young Choi; Seung Hyup Hyun; Chang-Seok Ki; Dongryul Oh; Yong Chan Ahn; Young Hyeh Ko; Sunkyu Choi; Sin-Ho Jung; Pek-Lan Khong; Tiffany Tang; Xuexian Yan; Soon Thye Lim; Yok-Lam Kwong; Won Seog Kim
Journal:  Lancet Haematol       Date:  2015-01-28       Impact factor: 18.959

Review 7.  Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.

Authors:  Ritsuro Suzuki
Journal:  Int J Hematol       Date:  2010-12-01       Impact factor: 2.490

Review 8.  Diagnosis and management of extranodal NK/T cell lymphoma nasal type.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Expert Rev Hematol       Date:  2016-07-08       Impact factor: 2.929

9.  Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.

Authors:  Wing-yan Au; Dennis D Weisenburger; Tanin Intragumtornchai; Shigeo Nakamura; Won-Seog Kim; Ivy Sng; Julie Vose; James O Armitage; Raymond Liang
Journal:  Blood       Date:  2008-11-24       Impact factor: 22.113
  9 in total
  14 in total

1.  Advances in Transplantation for Lymphomas Resulting from CIBMTR Lymphoma Working Committee's Research Portfolio: A Five-Year Report (2013-2018).

Authors:  Mehdi Hamadani
Journal:  Adv Cell Gene Ther       Date:  2018-08-30

Review 2.  NK/T Cell Lymphoma: Updates in Therapy.

Authors:  Ritsuro Suzuki
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

3.  Management of NK/T-Cell Lymphoma, Nasal Type.

Authors:  Pamela B Allen; Mary Jo Lechowicz
Journal:  J Oncol Pract       Date:  2019-10       Impact factor: 3.840

Review 4.  How we treat NK/T-cell lymphomas.

Authors:  Eric Tse; Wei-Li Zhao; Jie Xiong; Yok-Lam Kwong
Journal:  J Hematol Oncol       Date:  2022-06-03       Impact factor: 23.168

5.  EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.

Authors:  Lauren P McLaughlin; Rayne Rouce; Stephen Gottschalk; Vicky Torrano; George Carrum; Meng-Fen Wu; Fahmida Hoq; Bambi Grilley; Andrea M Marcogliese; Patrick J Hanley; Adrian P Gee; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop; Catherine M Bollard
Journal:  Blood       Date:  2018-09-27       Impact factor: 25.476

Review 6.  Extranodal NK/T cell lymphoma.

Authors:  Seong Hyun Jeong
Journal:  Blood Res       Date:  2020-07-31

7.  Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Authors:  Anne-Claire Mamez; Axelle Dupont; Didier Blaise; Patrice Chevallier; Edouard Forcade; Patrice Ceballos; Mohamad Mohty; Felipe Suarez; Yves Beguin; Regis Peffault De Latour; Marie-Thérèse Rubio; Olivier Tournilhac; Stéphanie Nguyen
Journal:  J Hematol Oncol       Date:  2020-05-19       Impact factor: 17.388

8.  Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis.

Authors:  Narendranath Epperla; Kwang W Ahn; Carlos Litovich; Sairah Ahmed; Minoo Battiwalla; Jonathon B Cohen; Parastoo Dahi; Nosha Farhadfar; Umar Farooq; Cesar O Freytes; Nilanjan Ghosh; Bradley Haverkos; Alex Herrera; Mark Hertzberg; Gerhard Hildebrandt; David Inwards; Mohamed A Kharfan-Dabaja; Farhad Khimani; Hillard Lazarus; Aleksandr Lazaryan; Lazaros Lekakis; Hemant Murthy; Sunita Nathan; Taiga Nishihori; Attaphol Pawarode; Tim Prestidge; Praveen Ramakrishnan; Andrew R Rezvani; Rizwan Romee; Nirav N Shah; Ana Sureda; Timothy S Fenske; Mehdi Hamadani
Journal:  J Hematol Oncol       Date:  2019-01-10       Impact factor: 17.388

Review 9.  Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment.

Authors:  Jaap A van Doesum; Anne G H Niezink; Gerwin A Huls; Max Beijert; Arjan Diepstra; Tom van Meerten
Journal:  Hemasphere       Date:  2021-01-12

10.  [How I diagnose and treat NK/T cell lymphoma].

Authors:  W L Zhao; M C Cai; H J Zhong
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.